carteolol has been researched along with metipranolol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Höh, H | 2 |
| Bringer, L; Dufier, JL; Hugues, FC; Le Jeunne, CL; Munera, Y | 1 |
| James, IM | 1 |
| Berlin, I; Le Hoang, P; Marcel, P; Millon, D; Puech, AJ; Uzzan, B | 1 |
| Dufier, JL; Hugues, FC; Le Jeunne, C; Munera, Y | 1 |
| Schnarr, KD | 1 |
| Hugues, FC; Le Jeunne, C; Munera, Y; Teillet, L | 1 |
| Zimmerman, TJ | 1 |
| Frishman, WH; Fuksbrumer, MS; Tannenbaum, M | 1 |
| Karaküçük, S; Mirza, GE; Temel, E | 1 |
| Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ | 1 |
3 review(s) available for carteolol and metipranolol
| Article | Year |
|---|---|
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol | 1989 |
Topical ophthalmic beta blockers: a comparative review.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol | 1993 |
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol | 1994 |
5 trial(s) available for carteolol and metipranolol
| Article | Year |
|---|---|
Surface anesthetic effect and subjective compatibility of 2% carteolol and 0.6% metipranolol in eye-healthy people.
Topics: Anesthesia, Local; Carteolol; Cornea; Double-Blind Method; Humans; Metipranolol; Placebos; Prospective Studies | 1990 |
[Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes].
Topics: Adult; Anesthetics, Local; Carteolol; Clinical Trials as Topic; Cornea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Metipranolol; Middle Aged; Nociceptors; Procaine; Propanolamines; Prospective Studies; Random Allocation; Sensory Thresholds | 1989 |
A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Carteolol; Double-Blind Method; Heart Rate; Humans; Intraocular Pressure; Isoproterenol; Male; Metipranolol; Ophthalmic Solutions; Random Allocation; Timolol | 1987 |
[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
Topics: Adult; Asthma; Blood Pressure; Carteolol; Clinical Trials as Topic; Female; Glaucoma; Heart; Heart Rate; Humans; Male; Metipranolol; Ophthalmic Solutions; Propanolamines; Respiration; Vital Capacity | 1987 |
Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Male; Metipranolol; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Treatment Outcome; Visual Field Tests; Visual Fields | 2000 |
6 other study(ies) available for carteolol and metipranolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
Topics: Adrenergic beta-Antagonists; Asthma; Carteolol; Female; Forced Expiratory Volume; Hemodynamics; Humans; Male; Metipranolol; Ophthalmic Solutions; Timolol; Vital Capacity | 1989 |
New topical beta-blockers for glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipranolol; Propanolamines | 1987 |
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Topics: Adrenergic beta-Antagonists; Carteolol; Drug Evaluation; Glaucoma; Humans; Intraocular Pressure; Metipranolol; Ophthalmic Solutions; Pindolol; Propanolamines; Time Factors; Timolol | 1988 |
[Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
Topics: Adult; Asthma; Blood Pressure; Carteolol; Heart Rate; Humans; Isoproterenol; Metipranolol; Middle Aged; Ophthalmic Solutions; Propanolamines; Respiration; Timolol | 1988 |
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol | 2000 |